Noninvasive ventilation immediately after extubation improves weaning outcome after acute respiratory failure: a randomized controlled trial

Carregando...
Imagem de Miniatura
Citações na Scopus
94
Tipo de produção
article
Data de publicação
2013
Título da Revista
ISSN da Revista
Título do Volume
Editora
BIOMED CENTRAL LTD
Autores
ORNICO, Susana R.
LOBO, Suzana M.
SANCHES, Helder S.
DEBERALDINI, Maristela
TOFOLI, Luciane T.
VIDAL, Ana M.
Citação
CRITICAL CARE, v.17, n.2, article ID R39, 10p, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: Noninvasive ventilation (NIV), as a weaning-facilitating strategy in predominantly chronic obstructive pulmonary disease (COPD) mechanically ventilated patients, is associated with reduced ventilator-associated pneumonia, total duration of mechanical ventilation, length of intensive care unit (ICU) and hospital stay, and mortality. However, this benefit after planned extubation in patients with acute respiratory failure of various etiologies remains to be elucidated. The aim of this study was to determine the efficacy of NIV applied immediately after planned extubation in contrast to oxygen mask (OM) in patients with acute respiratory failure (ARF). Methods: A randomized, prospective, controlled, unblinded clinical study in a single center of a 24-bed adult general ICU in a university hospital was carried out in a 12-month period. Included patients met extubation criteria with at least 72 hours of mechanical ventilation due to acute respiratory failure, after following the ICU weaning protocol. Patients were randomized immediately before elective extubation, being randomly allocated to one of the study groups: NIV or OM. We compared both groups regarding gas exchange 15 minutes, 2 hours, and 24 hours after extubation, reintubation rate after 48 hours, duration of mechanical ventilation, ICU length of stay, and hospital mortality. Results: Forty patients were randomized to receive NIV (20 patients) or OM (20 patients) after the following extubation criteria were met: pressure support (PSV) of 7 cm H2O, positive end-expiratory pressure (PEEP) of 5 cm H2O, oxygen inspiratory fraction (FiO(2)) <= 40%, arterial oxygen saturation (SaO(2)) >= 90%, and ratio of respiratory rate and tidal volume in liters (f/TV) < 105. Comparing the 20 patients (NIV) with the 18 patients (OM) that finished the study 48 hours after extubation, the rate of reintubation in NIV group was 5% and 39% in OM group (P = 0.016). Relative risk for reintubation was 0.13 (CI = 0.017 to 0.946). Absolute risk reduction for reintubation showed a decrease of 33.9%, and analysis of the number needed to treat was three. No difference was found in the length of ICU stay (P = 0.681). Hospital mortality was zero in NIV group and 22.2% in OM group (P = 0.041). Conclusions: In this study population, NIV prevented 48 hours reintubation if applied immediately after elective extubation in patients with more than 3 days of ARF when compared with the OM group.
Palavras-chave
Referências
  1. Antonelli M, 2008, CRIT CARE, V12, DOI 10.1186/cc6853
  2. Briel Matthias, 2012, J Bone Joint Surg Am, V94 Suppl 1, P56, DOI 10.2106/JBJS.K.01412
  3. Burns KE, 2010, COCHRANE DB SYST REV, V8
  4. Burns KEA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1574
  5. Chen Jie, 2001, Zhonghua Jiehe He Huxi Zazhi, V24, P99
  6. Epstein SK, 1997, CHEST, V112, P186, DOI 10.1378/chest.112.1.186
  7. Epstein SK, 1998, AM J RESP CRIT CARE, V158, P489
  8. Esteban A, 2004, NEW ENGL J MED, V350, P2452, DOI 10.1056/NEJMoa032736
  9. Ferrer M, 2009, LANCET, V374, P1082, DOI 10.1016/S0140-6736(09)61038-2
  10. Ferrer M, 2006, AM J RESP CRIT CARE, V173, P164, DOI 10.1164/rccm.200505-718OC
  11. Ferrer M, 2003, AM J RESP CRIT CARE, V168, P70, DOI 10.1164/rccm.200209-1074OC
  12. FERREYRA G, 2001, MINERVA ANESTESIOL, V77, P921
  13. Girault C, 1999, AM J RESP CRIT CARE, V160, P86
  14. Hill NS, 2000, AM J RESP CRIT CARE, V161, pB18
  15. Jiang J S, 1999, Respirology, V4, P161, DOI 10.1046/j.1440-1843.1999.00168.x
  16. Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238
  17. Keenan SP, 2011, CAN MED ASSOC J, V183, pE195, DOI 10.1503/cmaj.100071
  18. Luo Hong, 2001, Hunan Yike Daxue Xuebao, V26, P563
  19. Nava S, 1998, ANN INTERN MED, V128, P721
  20. Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7
  21. Nava S, 2005, CRIT CARE MED, V33, P2465, DOI 10.1097/01.CCM.0000186416.44752.72
  22. RABIE GM, 2004, CHEST S, V126, P755
  23. Su CL, 2012, RESP CARE, V57, P204, DOI 10.4187/respcare.01141
  24. Trevisan CE, 2008, CRIT CARE, V12, DOI 10.1186/cc6870
  25. Vaschetto R, 2012, INTENS CARE MED, V38, P1599, DOI 10.1007/s00134-012-2652-7
  26. Wang C, 2005, CHINESE MED J-PEKING, V118, P1589
  27. Zheng R, 2005, CHIN J EMERG MED, V14, P21
  28. [邹石海 ZOU Shihai], 2006, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V31, P120